Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb dose-finding study of inhaled VR004 (apomorphine) for erectile dysfunction
2005-005476-32Phase 2Completed
- Sponsor
- Vectura
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apomorphine in erectile dysfunction (ED) (4 arms), sponsored by Vectura. Primary endpoints: Primary endpoint – change in proportion of 'yes' responses and Dose-response efficacy comparison. Started Jan 2006; status: completed.
02
Drugs
apomorphine
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2005-005476-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005476-32.